Novartis recently announced its agreement to acquire Morphosys AG, a Germany-based biopharmaceutical company specializing in oncology medicines. This strategic move...
04.04.2016
- Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...
22.12.2014
- Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...
13.06.2014
- Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...
